Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  CYANOTECH CORP    CYAN

CYANOTECH CORP (CYAN)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 04/20 10:00:00 pm
4.2 USD   -5.62%
04/16CYANOTECH CORPO : CYAN) Files An 8-K Other Events
AQ
02/06CYANOTECH : Reports Financial Results for the Third Quarter of Fisca..
BU
01/30CYANOTECH : names new CEO
AQ
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Cyanotech : Names Mawae Morton President

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/18/2017 | 12:01am CEST

Cyanotech Corporation (Nasdaq Capital Market: CYAN) today announced that the Board of Directors has named Mawae Morton as President effective immediately. Mr. Morton will report directly to the Company’s Chief Executive Officer, Dr. Gerald Cysewski.

Cyanotech’s Chairman, Michael Davis said, “We are pleased that Mawae has chosen to join Cyanotech. He brings a deep understanding of complex bio-based operating businesses having held various executive positions in the bio-refinery and agriculture disciplines.” He continued, “Cyanotech has built its leadership position as a quality producer of high-value nutritional products and Mawae will significantly complement the company’s strengths with his business expertise.” Dr. Cysewski added, “Mawae has served as a strategic consultant to the Company over the last six months, made significant contributions, and will certainly hit the ground running. I look forward to continuing to work with him to move Cyanotech forward.”

Mr. Morton has served as a strategic consultant to the Company for the previous six months. Prior to that, he was the Chief Executive Officer of HBE BiorefineryCo, a Hawaii based forestry and bioenergy development company, and President of Matariki Group LLC, which provides consulting services for project development with a focus on renewable energy, forestry, agribusiness and environmental planning. Mr. Morton has also served as the Strategic Resource Manager for Kamehameha Schools, the largest land owner in Hawaii, and Managing Director at Merica International, a privately owned group of companies with global interests in the renewable energy sector. In New Zealand, Mr. Morton was a Senior Consultant with KPMG Consulting with projects in New Zealand, China, Singapore, Japan, and Silicon Valley, California. He holds a Master’s degree in Public Policy from Victoria University of Wellington and a Bachelor’s degree in agriculture from Massy University, in New Zealand.

About Cyanotech Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®—all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA-reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at our 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech sells its products direct to consumers at retail locations in the United States and online at www.nutrex-hawaii.com and also distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers. Visit www.cyanotech.com for more information.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CYANOTECH CORP
04/16CYANOTECH CORPORATION (NASDAQ : CYAN) Files An 8-K Other Events
AQ
04/13CYANOTECH CORP : Other Events (form 8-K)
AQ
02/06CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
02/06CYANOTECH : Reports Financial Results for the Third Quarter of Fiscal Year 2018
BU
01/30CYANOTECH : names new CEO
AQ
01/25CYANOTECH CORP : Change in Directors or Principal Officers, Other Events, Financ..
AQ
01/24CYANOTECH : Names Mawae Morton as Chief Executive Officer and a Member of the Bo..
BU
2017CYANOTECH : earns $475K in second quarter
AQ
2017CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2017CYANOTECH : Reports Financial Results for the Second Quarter of Fiscal Year 2018
BU
More news
News from SeekingAlpha
04/18CYANOTECH : An Opportune Moment To Buy 
04/16Midday Gainers / Losers (04/16/2018) 
04/16HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (04/16/2018) 
02/06Midday Gainers / Losers (2/6/2018) 
02/06HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (2/6/2018) 
Chart CYANOTECH CORP
Duration : Period :
CYANOTECH CORP Technical Analysis Chart | CYAN | US2324373016 | 4-Traders
Managers
NameTitle
Mawae Morton Chief Executive Officer & Director
Michael A. Davis Chairman
Gerard J. Watts Chief Operating Officer
Jolé Eileen Deal CFO, Secretary, Treasurer & VP-Administration
Gerald R. Cysewski Vice Chairman & Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
CYANOTECH CORP7.44%0
CSL LIMITED13.09%55 896
BIOGEN-17.44%55 645
ALEXION PHARMACEUTICALS-6.56%23 966
GRIFOLS-4.16%17 743
BIOMARIN PHARMACEUTICAL-6.22%14 491